CASP3 and cancer: Treatment of cancer cell lines (A431 epidermoid carcinoma, MDA-MB-231 breast carcinoma) with gefitinib (EGFR inhibitor) or camptothecin (topoisomerase inhibitor) triggered apoptosis, as evidenced by elevated levels of cleaved caspase-3.